ホーム › 無症候性多発性骨髄腫 › ニューヨーク
ニューヨークにおける無症候性多発性骨髄腫の臨床試験
ニューヨーク内の拠点で、無症候性多発性骨髄腫に関する8件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07393282Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- Hematology Oncology Associates of CNY at Camillus, Camillus
- Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse
- Mount Sinai Chelsea, New York
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/19更新 · NCT03937635A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
- NYU Langone Health Perlmutter Cancer Center, New York
- Stony Brook University Hospital, Stony Brook
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/08更新 · NCT06140524A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
- Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 他1件
被験者募集中
18歳以上 · 全性別 · 2026/04/16更新 · NCT05640843Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
- Roswell Park Cancer Institute, Buffalo
被験者募集中
18歳以上 · 全性別 · 2025/12/01更新 · NCT05312255A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 他1件
被験者募集中
18歳以上 · 全性別 · 2025/11/13更新 · NCT06055894Screening for AL Amyloidosis in Smoldering Multiple Myeloma
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中観察研究
40歳以上 · 全性別 · 2025/08/06更新 · NCT06365060Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
- University of Rochester, Rochester
被験者募集中第2相
18歳以上 · 全性別 · 2025/02/10更新 · NCT05597345ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。